Atezolizumab in Combination with Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients with Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer(Bio-Marker Lab Clinical Research)
Administered By
Awarded By
Contributors
- Secord, Angeles Alvarez Principal Investigator
Start/End
- February 2, 2018 - February 1, 2022